The centre wants 300 to 400 million doses of the coronavirus vaccine being developed by the Oxford University and pharma company AstraZeneca by July, Serum Institute's Adar Poonawalla, said on Saturday. Referring to Prime Minister Narendra Modi's visit to a company facility today to review the vaccine's development, Mr Poonawalla said "we are amazed with what he already knew".
India has reported 41,322 fresh COVID-19 cases on Saturday, 4% lower than on Friday, taking its overall number to 93.51 lakh cases and 1,36,200 deaths, Union Health Ministry data shows. These numbers come even as a vaccine to fight back the virus seemed tantalisingly close. The states of Maharashtra, Karnataka, Andhra Pradesh, Tamil Nadu, and Kerala were the most affected ones, with deaths ranging from 23 to 85 in the past 24 hours.
PM Modi began his three-city vaccine tour with a visit to pharma major Zydus Cadila's plant near Ahmedabad. He then visited Pune where Serum Institute of India (SII), which has partnered with global pharma giant AstraZeneca and Oxford University for a COVID-19 vaccine, is based.
On November 24, Prime Minister while speaking with chief ministers of various states over the deteriorating pandemic situation in their states at a virtual meeting advised the states to establish cold storage facilities for COVID-19 vaccine beforehand and suggested them to prepare and send a plan for its distribution to the Central government. Delhi registered 5,482 fresh COVID-19 cases in a day, while 98 more fatalities linked to the disease pushed the city's death count to 8,909 on Friday, authorities said.
Here are the Highlights on Coronavirus Cases:
The COVID-19 positivity rate in Delhi dropped to 7.24 per cent on Saturday, the lowest since October 23.
"Since 7 November, cases and positivity in Delhi are going down. Today, less than 5000 cases, 89 deaths and 7.24 positivity. Hope this trend continues. Delhiites and Delhi govt together will win over this third wave also. Pl continue to observe all precautions," Chief Minister Arvind Kejriwal tweeted.
The Rajasthan government on Saturday fixed the rate for COVID-19 RT-PCR tests by private labs in the state to Rs 800, slashing it by Rs 400, news agency PTI reported.
- At the moment, the trials were more than enough for the efficacy. We might later on look at doing trials on the group less than 18 years of age.
- We are talking about how to distribute it, where to distribute, also about the price, so it can be affordable, how many doses will go where. We are trying to get to the number to 300-400 million doses by July
- Even if we get the approval two months later, it will not make much difference to the delivery.
- We got good efficacy results. Zero hospitalisation among those who took it. Even those who got the disease were not infecting, which is a very good bonus to have for the disease, which is so infectious.
"We are amazed with what he already knew. He was impressed with the new facility that we have built. We have showed him a new facility so that we can deal with more than one billion doses"
- As of yet, we don't have anything in writing as in how many doses the Government of India will purchase.
- We are in the process of applying, in the next 2 weeks, for the emergency use.
- PM Modi has great knowledge about the vaccine. We didn't need to explain much to him.
"What we discussed is the implementation plan only after we get the emergency use approval after we make the submissions. After that, the health ministry will roll out the doses in first and second quarter. But, that is after we have made the submissions and everything is approved"
"Today, honourable Prime Minister Narendra Modi visited our Zydus Biotech park. This visit has encouraged us in doing more and doing fast," the company's Chairman Pankaj Patel was quoted by PTI as saying in a video.
PM Modi today visited a facility of Bharat BioTech, which is working on Covaxin, pitched as India's first indigenous vaccine candidate. The company later released a statement: "The prime minister's visit serves as a great inspiration to our team, and further reinforces our commitment towards scientific discovery, solving public health issues, and the nation's fight against COVID-19".
The Tamil Nadu government has contained the spread of coronavirus through focused and concerted efforts and is now engaged in efforts to ensure that normalcy returns to the state, Chief Minister K Palaniswami said on Saturday.
"We have observed that whenever there is a large gathering like a wedding or when people step out of their homes, some wear face masks while others ignore the precaution," the Chief Minister was quoted by news agency PTI as saying.
At the Bharat Biotech facility in Hyderabad, was briefed about their indigenous COVID-19 vaccine. Congratulated the scientists for their progress in the trials so far. Their team is closely working with ICMR to facilitate speedy progress. pic.twitter.com/C6kkfKQlbl
- Narendra Modi (@narendramodi) November 28, 2020
Visited the Zydus Biotech Park in Ahmedabad to know more about the indigenous DNA based vaccine being developed by Zydus Cadila. I compliment the team behind this effort for their work. Government of India is actively working with them to support them in this journey. pic.twitter.com/ZIZy9NSY3o
- Narendra Modi (@narendramodi) November 28, 2020
Delhi: Tractors of farmers at the approved protest site- Nirankari Samagam Ground in Burari, being sanitised by a municipal worker pic.twitter.com/18yjQzQjTG
- ANI (@ANI) November 28, 2020
Dehradun: All shops except those selling essential items will remain closed on sundays due to surge in #COVID19 cases
- ANI (@ANI) November 28, 2020
Restrictions have to be placed as COVID19 cases are increasing in the city: Dr Ashish K Srivastav, District Magistrate #Uttarakhand (file pic) pic.twitter.com/oc4t2jgVYB
#WATCH Prime Minister Narendra Modi visits Zydus Biotech Park in Ahmedabad, reviews the development of #COVID19 vaccine candidate ZyCOV-D pic.twitter.com/vEhtNMf1YE
- ANI (@ANI) November 28, 2020
Gujarat: PM Narendra Modi to visit Zydus Biotech Park in Ahmedabad, Bharat Biotech in Hyderabad & Serum Institute of India in Pune today to personally review the #COVID19 vaccine development and manufacturing process.
- ANI (@ANI) November 28, 2020
Visuals from Zydus Biotech Park in Ahmedabad. pic.twitter.com/sAE3b2cWgO